Latest Trade Alerts

Brokerage Partners

BUSINESS

Analysts' Actions: FB CBI COH EXC PMCS

Tickers in this article: CBI COH EXC FB PMCS ADVS HCBK

NEW YORK (TheStreet) -- CHANGE IN RATINGS

Advent Software (ADVS) downgraded at Wedbush to Neutral from Outperform, Wedbush said. $30 price target. Bookings could slow, along with the rest of the market.

Advanced Energy Industries (AEIS) upgraded to buy at TheStreet Ratings.

Alkermes PLC (ALKS) upgraded to buy at TheStreet Ratings.

Chicago Bridge & Iron (CBI) downgraded at Credit Suisse from Outperform to Neutral, Credit Suisse said. $39 price target. Shaw deal adds risk to the investment thesis.

Chicago Bridge & Iron downgraded at Lazard from Buy to Neutral, Lazard said. Shaw purchase is a divergence from the company's de-risking strategy.

Coach(COH) downgraded at Piper from Overweight to Neutral, Piper Jaffray said. $67 price target. Company will spend a few quarters investing in future growth.

Exelon (EXC) rated new Equal-weight at Morgan Stanley. Valuation call, based on a $40 price target.

Facebook (FB) upgraded at Bernstein from Underperform to Market Perform, Bernstein said. Valuation call, based on a $23 price target.

Hudson City Bancorp (HCBK) upgraded at Guggenheim to Buy from Neutral, Guggenheim said. $7 price target. Earnings should bottom in the third quarter.

PMC Sierra (PMCS) downgraded at Wunderlich to Hold, Wunderlich said. $6.50 price target. CFO left and the company has pushed out its timeline for a potential recovery.

Shaw Group (SHAW) downgraded at UBS to Neutral from Buy, UBS said. $44 price target. Stock generally prices in acquisition.

Unisource Energy (UNS) downgraded at DA Davidson from Buy to Neutral, DA Davidson said. Valuation call, following a 14% run in the stock.

Vertex Pharmaceuticals (VRTX) downgraded at Piper from Overweight to Neutral, Piper Jaffray said. $57 price target. Company is realizing lower Incivek sales.

Watsco (WSO) rated new Neutral at Lazard. Valuation call.

STOCK COMMENTS / EPS CHANGES

Anadarko Petroleum (APC) estimates raised at UBS through 2013, UBS said. Strong 2Q and guidance raise. Buy rating and $105 price target.